Literature DB >> 15812216

Glucose transporter-1 expression in urothelial papilloma of the bladder.

Jee-Hyun Lee1, Youn-Wha Kim, Sung-Goo Chang.   

Abstract

INTRODUCTION: Urothelial papilloma should be distinguished from low-grade urothelial carcinoma. We report our experience with glucose transporter-1 (Glut-1) expression in urothelial papilloma.
MATERIALS AND METHODS: From January 1987 to December 2002, 32 patients with papilloma were diagnosed. Glut-1 protein expression was studied in 32 cases of papilloma and 30 cases of carcinoma. Clinical information was obtained by chart review.
RESULTS: Mean age was 54.7 years, and the solitary lesion was 78.1%. No case of bladder papilloma expressed Glut-1 protein even in cases of recurrent papilloma. However, 67% of urothelial carcinoma specimens were stained for Glut-1 protein. Two patients developed recurrent papilloma (6.2%), 1 of whom (3.1%) developed an urothelial carcinoma 4 years after diagnosis of papilloma.
CONCLUSIONS: The study showed that papilloma does not express the Glut-1 protein in contrast to urothelial carcinoma. This distinctive expression pattern of Glut-1 will possibly contribute to differentiate urothelial papilloma from low-grade urothelial carcinoma. Copyright 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15812216     DOI: 10.1159/000083561

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  5 in total

Review 1.  Targeting glycogen metabolism in bladder cancer.

Authors:  Carolyn Ritterson Lew; Sunny Guin; Dan Theodorescu
Journal:  Nat Rev Urol       Date:  2015-05-26       Impact factor: 14.432

2.  Glycosylated phospholipid-coated upconversion nanoparticles for bioimaging of non-muscle invasive bladder cancers.

Authors:  Bowen Sun; Sneha Sree Mullapudi; Yong Zhang; Koon Gee Neoh
Journal:  Mikrochim Acta       Date:  2022-08-25       Impact factor: 6.408

3.  Expression of GLUT1 is associated with increasing grade of malignancy in non-invasive and invasive urothelial carcinomas of the bladder.

Authors:  Henning Reis; Stephan Tschirdewahn; Tibor Szarvas; Herbert Rübben; Kurt Werner Schmid; Florian Grabellus
Journal:  Oncol Lett       Date:  2011-08-29       Impact factor: 2.967

4.  Evaluating the expression of GLUT-1 in oral leukoplakia.

Authors:  Daffney Mano Doss; Madhava Nirmal; R Saravanan; A Venkatesh
Journal:  J Oral Maxillofac Pathol       Date:  2020-09-09

5.  Glucose transporters as markers of diagnosis and prognosis in cancer diseases.

Authors:  Leszek Szablewski
Journal:  Oncol Rev       Date:  2022-02-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.